Gingivitis - Pipeline Review, H1 2016 Summary Global Markets Direct's, 'Gingivitis - Pipeline Review, H1 2016', provides an overview of the Gingivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gingivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gingivitis and features dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Gingivitis - The report reviews pipeline therapeutics for Gingivitis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Gingivitis therapeutics and enlists all their major and minor projects - The report assesses Gingivitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Gingivitis Reasons To Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Gingivitis - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Gingivitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Gingivitis Overview 7 Therapeutics Development 8 Pipeline Products for Gingivitis - Overview 8 Pipeline Products for Gingivitis - Comparative Analysis 9 Gingivitis - Therapeutics under Development by Companies 10 Gingivitis - Therapeutics under Investigation by Universities/Institutes 11 Gingivitis - Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Unknown Stage Products 14 Gingivitis - Products under Development by Companies 15 Gingivitis - Products under Investigation by Universities/Institutes 16 Gingivitis - Companies Involved in Therapeutics Development 17 TGV-Laboratories 17 VivaCell Biotechnology Espana S.L. 18 Gingivitis - Therapeutics Assessment 19 Assessment by Monotherapy Products 19 Assessment by Target 20 Assessment by Mechanism of Action 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 28 BLXA-4ME - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 CDE-001 - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 KSL-W - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Mul-1867 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 ST-266 - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Gingivitis - Recent Pipeline Updates 34 Gingivitis - Dormant Projects 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 36 Disclaimer 37
List of Tables
Number of Products under Development for Gingivitis, H1 2016 8 Number of Products under Development for Gingivitis - Comparative Analysis, H1 2016 9 Number of Products under Development by Companies, H1 2016 10 Number of Products under Investigation by Universities/Institutes, H1 2016 11 Comparative Analysis by Clinical Stage Development, H1 2016 12 Comparative Analysis by Early Stage Development, H1 2016 13 Comparative Analysis by Unknown Stage Development, H1 2016 14 Products under Development by Companies, H1 2016 15 Products under Investigation by Universities/Institutes, H1 2016 16 Gingivitis - Pipeline by TGV-Laboratories, H1 2016 17 Gingivitis - Pipeline by VivaCell Biotechnology Espana S.L., H1 2016 18 Assessment by Monotherapy Products, H1 2016 19 Number of Products by Stage and Target, H1 2016 21 Number of Products by Stage and Mechanism of Action, H1 2016 23 Number of Products by Stage and Route of Administration, H1 2016 25 Number of Products by Stage and Molecule Type, H1 2016 27 Gingivitis Therapeutics - Recent Pipeline Updates, H1 2016 34 Gingivitis - Dormant Projects, H1 2016 35
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.